Literature DB >> 9349494

Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy.

K L Brown1, K Stewart, M E Bruce, H Fraser.   

Abstract

Following combined intraperitoneal and intracerebral injection with bovine spongiform encephalopathy (BSE) cow brain homogenate, SCID mice show a resistance to infection in comparison with immunocompetent CB20 mice. BSE occurred in only five out of 22 challenged SCID mice, with a mean incubation period of 573 days, whereas all the CB20 mice developed the disease with a mean incubation period of 456 days. In contrast, previous studies have shown that intracerebral infection of SCID mice with a mouse-passaged scrapie strain, ME7, produces 100% incidence of disease but no replication of infectivity in spleen. The results with BSE suggest that there is little or no direct infection of the CNS in interspecies transmissions, but that processing or replication of infectivity in peripheral lymphoid tissues may facilitate subsequent spread of infection to the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349494     DOI: 10.1099/0022-1317-78-10-2707

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells.

Authors:  Catherine Rybner-Barnier; Catherine Jacquemot; Céline Cuche; Grégory Doré; Laleh Majlessi; Marie-Madeleine Gabellec; Arnaud Moris; Olivier Schwartz; James Di Santo; Ana Cumano; Claude Leclerc; Françoise Lazarini
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice.

Authors:  K Manolakou; J Beaton; I McConnell; C Farquar; J Manson; N D Hastie; M Bruce; I J Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice.

Authors:  A J Raeber; M A Klein; R Frigg; E Flechsig; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

5.  Scrapie pathogenesis in subclinically infected B-cell-deficient mice.

Authors:  R Frigg; M A Klein; I Hegyi; R M Zinkernagel; A Aguzzi
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 6.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

7.  Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease Susceptibility.

Authors:  David S Donaldson; Anuj Sehgal; Daniel Rios; Ifor R Williams; Neil A Mabbott
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

Review 8.  How do PrPSc Prions Spread between Host Species, and within Hosts?

Authors:  Neil A Mabbott
Journal:  Pathogens       Date:  2017-11-24

9.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.

Authors:  S Köhler; S Ullrich; U Richter; U Schumacher
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.